Home / Feed item / OIRM: New FDA regulation to restrict marketing of unproven stem cell therapies in US but leaves long 36 month window for compliance. http://lat.ms/2mT1LnA
OIRM: New FDA regulation to restrict marketing of unproven stem cell therapies in US but leaves long 36 month window for compliance. http://lat.ms/2mT1LnA
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.
